Pharmacologic or gene therapy-mediated HO-1 upregulation protects the fetus from rejection (Sollwedel et al., 2005; Zenclussen et al., 2006) revealing the therapeutic potential of HO-1 in the treatment of pregnancy disorders. This evidence concerns the gene HMOX1 and pregnancy disorder.